financetom
Business
financetom
/
Business
/
Moonlake Immunotherapeutics Insider Sold Shares Worth $1,146,565, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Moonlake Immunotherapeutics Insider Sold Shares Worth $1,146,565, According to a Recent SEC Filing
Jul 7, 2025 1:19 PM

04:08 PM EDT, 07/07/2025 (MT Newswires) -- Catherine Moukheibir, Director, on July 03, 2025, sold 23,500 shares in Moonlake Immunotherapeutics ( MLTX ) for $1,146,565.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1821586/000121390025061752/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved